Find uplifting stories about heroes, innovations, and solutions
84 results for "pulmonary fibrosis"
Researchers discovered how a protein called vitronectin triggers deadly lung scarring, opening the door to new treatments for a disease that currently has no cure. The breakthrough could help thousands living with pulmonary fibrosis breathe easier.
Scientists have created a precise gene-editing tool that could offer permanent treatment for cystic fibrosis patients, potentially replacing daily medications that cost hundreds of thousands of dollars per year. The breakthrough could transform care for people living with this and other genetic diseases.
An 80th birthday celebration in Northern Ireland became a powerful tribute to a late husband, raising over €1,200 for pulmonary fibrosis support. The donation will help provide respite care and resources for families battling the progressive lung disease.
A groundbreaking medication approved in 2024 is transforming life for pulmonary hypertension patients who once faced a grim prognosis. Inspired by NASA's Artemis II mission, advocates remind us that big dreams and research funding make medical miracles possible.
Scientists at the University of Trento developed the first gene therapy for 10% of cystic fibrosis patients who had no treatment options until now. The breakthrough could lead to a permanent cure instead of lifelong drug dependence.
Australian researchers developed an AI system that makes gene editing safer by protecting healthy genes during treatment. The breakthrough could transform how doctors treat genetic diseases like cystic fibrosis.
A new genetic testing approach at Mayo Clinic is transforming how doctors diagnose and treat pulmonary fibrosis, changing treatment plans for more than half of patients studied. The breakthrough combines telomere measurement with DNA testing to uncover hidden disease causes.
A chance discovery involving frog eggs led to medications that transformed cystic fibrosis from a death sentence into a manageable condition. Dr. Mike Welsh just won biomedicine's highest honor for research that saved thousands of lives.
Japan has approved a groundbreaking new treatment for two deadly lung diseases, offering hope to thousands of patients who've had limited options for over ten years. The drug slows lung function decline and could transform how doctors treat these life-threatening conditions.
More than 500,000 Europeans living with deadly lung scarring diseases just got their first new treatment option in over a decade. The oral medication slows lung function decline and doesn't require the burdensome liver monitoring older treatments demand.
A breakthrough cystic fibrosis drug may also transform diabetes outcomes for 30% of Australian CF patients who develop the condition. New research will investigate whether Trikafta can prevent or slow cystic fibrosis-related diabetes.
Scientists are developing better treatments for idiopathic pulmonary fibrosis, a deadly lung disease that kills most patients within five years. Understanding the genetic and environmental causes is finally leading to hope for the 3 million people affected worldwide.
Scientists discovered a genetic link that could finally explain why some people develop a deadly lung disease. A breakthrough drug tested in mice offers hope for millions living with idiopathic pulmonary fibrosis.
Scientists found a molecular switch that tells lung cells whether to repair damage or fight infection. The discovery could lead to new treatments for chronic lung diseases like COPD and pulmonary fibrosis.
Korean ballad legend Yoo Yeol nearly died from pulmonary fibrosis, dropping to just 88 pounds during six months in intensive care. Now he's back on stage after a successful lung transplant, calling his recovery "a miracle" that surprised even his doctors.
Crown Princess Mette-Marit of Norway successfully received a new lung at Oslo University Hospital, offering hope after an eight-year battle with a rare lung disease. The 52-year-old royal is recovering well under close medical supervision.
Researchers have discovered what causes devastating scar tissue in Crohn's disease patients, opening the door to treatments that could prevent scarring rather than just treating inflammation. For the first time, scientists can target the root cause of fibrosis that sends thousands to surgery each year.
A breakthrough drug combination is giving families living with cystic fibrosis real hope for healthier futures. German researchers just proved the treatment reduces dangerous inflammation for years, not just months.
A major European survey reveals what drives doctors to prescribe the life-changing cystic fibrosis drug Kaftrio to patients with stable lungs. The findings could help thousands more patients access treatment earlier.
Adults with cystic fibrosis-related diabetes needed significantly less insulin after one year on Kaftrio, offering hope for reduced treatment burden. The French study of 107 patients also found more stable blood sugar levels and dramatic improvements in lung function.
Showing 20 of 84